Q32 Bio (QTTB) Enterprise Value Growth (1y) (2018 - 2026)
Q32 Bio (QTTB) Enterprise Value Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.50% |
| Dec 31, 2025 | -7,364.76% |
| Sep 30, 2025 | 22.60% |
| Jun 30, 2025 | 49.06% |
| Mar 31, 2025 | 51.61% |
| Dec 31, 2024 | 88.54% |
| Sep 30, 2024 | -11.58% |
| Jun 30, 2024 | -53.06% |
| Mar 31, 2024 | -16.43% |
| Dec 31, 2023 | 96.77% |
| Sep 30, 2023 | 60.30% |
| Jun 30, 2023 | 68.81% |
| Mar 31, 2023 | 54.62% |
| Dec 31, 2022 | -10.90% |
| Sep 30, 2022 | -7.21% |
| Jun 30, 2022 | -5.11% |
| Mar 31, 2022 | -35.77% |
| Dec 31, 2021 | 27.84% |
| Sep 30, 2021 | -4.62% |
| Jun 30, 2021 | -3.83% |